drugset / Trial / NCT02495012
Anfibatide Treatment in STEMI Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
A Phase IIb clinical trial to investigate the safety and efficacy of antiplatelet thrombolysin injection for patients with ST Segment Elevation Myocardial Infarction (STEMI) before receiving PCI therapy, in order to provide evidence for Phase III design.
Timeline
- Start
- 2015-08
- Primary completion
- 2016-03
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Anfibatide | Protein / enzyme biologic | 0.002 iu/kg | Other |